A

APT Medical Inc
SSE:688617

Watchlist Manager
APT Medical Inc
SSE:688617
Watchlist
Price: 355.94 CNY -0.47% Market Closed
Market Cap: 34.7B CNY
Have any thoughts about
APT Medical Inc?
Write Note

APT Medical Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

APT Medical Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
APT Medical Inc
SSE:688617
Cash from Operating Activities
ÂĄ689.1m
CAGR 3-Years
67%
CAGR 5-Years
106%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Operating Activities
ÂĄ1.8B
CAGR 3-Years
9%
CAGR 5-Years
26%
CAGR 10-Years
28%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Operating Activities
ÂĄ14.4B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Operating Activities
ÂĄ1.2B
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash from Operating Activities
ÂĄ809.6m
CAGR 3-Years
-34%
CAGR 5-Years
-15%
CAGR 10-Years
11%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Operating Activities
ÂĄ132.5m
CAGR 3-Years
-66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

APT Medical Inc
Glance View

Market Cap
34.3B CNY
Industry
Health Care

APT Medical Inc. is a company embedded in the intricate world of medical devices, specializing in the development, production, and distribution of cardiovascular and peripheral vascular medical products. The company’s foundation rests on its ability to innovate and provide solutions that address the complex challenges faced by healthcare professionals in the treatment of heart and vascular diseases. APT Medical strategically focuses on minimally invasive technologies, which are increasingly preferred for their reduced patient recovery times and overall improvement in procedural success rates. By keeping its pulse on the evolving demands within the healthcare sector, APT Medical efficiently aligns its research and development initiatives to meet the global standards and expectations. Revenue streams for APT Medical Inc. flow primarily from its broad portfolio of interventional medical devices, such as guidewires, balloon catheters, and vascular closure devices. The intricacy of their manufacturing processes, coupled with stringent regulatory requirements, ensures that their offerings are both high in quality and competitively priced. Through a network of strategic partnerships, distribution channels, and a robust export framework, the company extends its reach across several international markets. By maintaining a keen focus on customer service and post-market support, APT Medical not only thrives on initial sales but also secures a steady stream of revenue from recurring purchases and long-term partnerships with healthcare institutions globally.

Intrinsic Value
343.06 CNY
Overvaluation 4%
Intrinsic Value
Price
A

See Also

What is APT Medical Inc's Cash from Operating Activities?
Cash from Operating Activities
689.1m CNY

Based on the financial report for Dec 31, 2023, APT Medical Inc's Cash from Operating Activities amounts to 689.1m CNY.

What is APT Medical Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
106%

Over the last year, the Cash from Operating Activities growth was 88%. The average annual Cash from Operating Activities growth rates for APT Medical Inc have been 67% over the past three years , 106% over the past five years .

Back to Top